Cargando…

Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia

BACKGROUND: While additional oxygen supply is often required for the survival of very premature infants in intensive care, this also brings an increasing risk of progressive lung diseases and poor long-term lung outcomes. Caffeine is administered to neonates in neonatal intensive care for the preven...

Descripción completa

Detalles Bibliográficos
Autores principales: Endesfelder, Stefanie, Strauß, Evelyn, Scheuer, Till, Schmitz, Thomas, Bührer, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511176/
https://www.ncbi.nlm.nih.gov/pubmed/31077204
http://dx.doi.org/10.1186/s12931-019-1063-5
_version_ 1783417534759829504
author Endesfelder, Stefanie
Strauß, Evelyn
Scheuer, Till
Schmitz, Thomas
Bührer, Christoph
author_facet Endesfelder, Stefanie
Strauß, Evelyn
Scheuer, Till
Schmitz, Thomas
Bührer, Christoph
author_sort Endesfelder, Stefanie
collection PubMed
description BACKGROUND: While additional oxygen supply is often required for the survival of very premature infants in intensive care, this also brings an increasing risk of progressive lung diseases and poor long-term lung outcomes. Caffeine is administered to neonates in neonatal intensive care for the prevention and treatment of apneas and has been shown to reduce BPD incidence and the need for mechanical ventilation, although it is still unclear whether this is due to a direct pulmonary action via antagonism of adenosine receptors and/or an indirect action. This experimental study aims to investigate the action of caffeine on the oxidative stress response in pulmonary tissue in a hyperoxia-based model of bronchopulmonary dysplasia in newborn rats. METHODS: Newborn Wistar rats were exposed to 21% or 80% oxygen for 3 (P3) or 5 (P5) postnatal days with or without recovery on room air until postnatal day 15 (P15) and treated with vehicle or caffeine (10 mg/kg) every 48 h beginning on the day of birth. The lung tissue of the rat pups was examined for oxidative stress response at P3 and P5 immediately after oxygen exposure or after recovery in ambient air (P15) by immunohistological staining and analysis of lung homogenates by ELISA and qPCR. RESULTS: Lungs of newborn rats, corresponding to the saccular stage of lung development and to the human lung developmental stage of preterms, showed increased rates of total glutathione and hydrogen peroxide, oxidative damage to DNA and lipids, and induction of second-phase mediators of antioxidative stress response (superoxide dismutase, heme oxygenase-1, and the Nrf2/Keap1 system) in response to hyperoxia. Caffeine reduced oxidative DNA damage and had a protective interference with the oxidative stress response. CONCLUSION: In addition to the pharmacological antagonism of adenosine receptors, caffeine appears to be a potent antioxidant and modulates the hyperoxia-induced pulmonary oxidative stress response and thus protective properties in the BPD-associated animal model. Free-radical-induced damage caused by oxidative stress seems to be a biological mechanism progress of newborn diseases. New aspects of antioxidative therapeutic strategies to passivate oxidative stress-related injury should be in focus of further investigations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-019-1063-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6511176
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65111762019-05-20 Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia Endesfelder, Stefanie Strauß, Evelyn Scheuer, Till Schmitz, Thomas Bührer, Christoph Respir Res Research BACKGROUND: While additional oxygen supply is often required for the survival of very premature infants in intensive care, this also brings an increasing risk of progressive lung diseases and poor long-term lung outcomes. Caffeine is administered to neonates in neonatal intensive care for the prevention and treatment of apneas and has been shown to reduce BPD incidence and the need for mechanical ventilation, although it is still unclear whether this is due to a direct pulmonary action via antagonism of adenosine receptors and/or an indirect action. This experimental study aims to investigate the action of caffeine on the oxidative stress response in pulmonary tissue in a hyperoxia-based model of bronchopulmonary dysplasia in newborn rats. METHODS: Newborn Wistar rats were exposed to 21% or 80% oxygen for 3 (P3) or 5 (P5) postnatal days with or without recovery on room air until postnatal day 15 (P15) and treated with vehicle or caffeine (10 mg/kg) every 48 h beginning on the day of birth. The lung tissue of the rat pups was examined for oxidative stress response at P3 and P5 immediately after oxygen exposure or after recovery in ambient air (P15) by immunohistological staining and analysis of lung homogenates by ELISA and qPCR. RESULTS: Lungs of newborn rats, corresponding to the saccular stage of lung development and to the human lung developmental stage of preterms, showed increased rates of total glutathione and hydrogen peroxide, oxidative damage to DNA and lipids, and induction of second-phase mediators of antioxidative stress response (superoxide dismutase, heme oxygenase-1, and the Nrf2/Keap1 system) in response to hyperoxia. Caffeine reduced oxidative DNA damage and had a protective interference with the oxidative stress response. CONCLUSION: In addition to the pharmacological antagonism of adenosine receptors, caffeine appears to be a potent antioxidant and modulates the hyperoxia-induced pulmonary oxidative stress response and thus protective properties in the BPD-associated animal model. Free-radical-induced damage caused by oxidative stress seems to be a biological mechanism progress of newborn diseases. New aspects of antioxidative therapeutic strategies to passivate oxidative stress-related injury should be in focus of further investigations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-019-1063-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-10 2019 /pmc/articles/PMC6511176/ /pubmed/31077204 http://dx.doi.org/10.1186/s12931-019-1063-5 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Endesfelder, Stefanie
Strauß, Evelyn
Scheuer, Till
Schmitz, Thomas
Bührer, Christoph
Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia
title Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia
title_full Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia
title_fullStr Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia
title_full_unstemmed Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia
title_short Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia
title_sort antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511176/
https://www.ncbi.nlm.nih.gov/pubmed/31077204
http://dx.doi.org/10.1186/s12931-019-1063-5
work_keys_str_mv AT endesfelderstefanie antioxidativeeffectsofcaffeineinahyperoxiabasedratmodelofbronchopulmonarydysplasia
AT straußevelyn antioxidativeeffectsofcaffeineinahyperoxiabasedratmodelofbronchopulmonarydysplasia
AT scheuertill antioxidativeeffectsofcaffeineinahyperoxiabasedratmodelofbronchopulmonarydysplasia
AT schmitzthomas antioxidativeeffectsofcaffeineinahyperoxiabasedratmodelofbronchopulmonarydysplasia
AT buhrerchristoph antioxidativeeffectsofcaffeineinahyperoxiabasedratmodelofbronchopulmonarydysplasia